GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bio-Techne TECH · USD

Health Care · Life Sciences Tools & Services · US listing · 🇺🇸 United States

S&P 500

Compare

72.83

+0.07%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

19 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 0Strong buy
  • 0Buy
  • 15Hold
  • 1Sell
  • 3Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Last close 72.83Average target 65.78

Low
50.00
Average
65.78
Median
73.00
High
73.00

Forecasts

Analyst averages for the fiscal years ahead

FY2027FY2028FY2029FY2030FY2031
Revenue$1.27bn$1.40bn$1.57bn$1.72bn$1.96bn
Revenue, highest$1.29bn$1.43bn$1.65bn$1.78bn$2.04bn
Revenue, lowest$1.25bn$1.39bn$1.49bn$1.67bn$1.91bn
Earnings per share2.052.362.432.67—
Earnings per share, highest2.192.492.552.81—
Earnings per share, lowest1.862.202.352.58—
Analysts107421

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast0.550.440.430.510.520.390.390.50
Reported0.530.460.420.530.560.420.420.49
Difference-3.3%+4.0%-2.0%+4.1%+7.4%+6.6%+7.7%-2.8%

Rating changes

Latest broker notes

  • Wells FargoOverweight → Equal Weight
  • RBC CapitalOutperform → Sector Perform
  • TD CowenBuy → Hold
  • BenchmarkBuy → Hold
  • CitigroupBuy → Neutral
  • William BlairOutperform → Market Perform
  • Stephens & Co.Overweight → Equal Weight
  • BairdNeutral
  • Wells FargoOverweight
  • Evercore ISI GroupIn Line
  • CitigroupBuy
  • Evercore ISI GroupIn Line

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

4 / 10

Revenue growth 9.3% a year over 10 years. Return on equity 8.5%.

Model fair value

85.72

From earnings 85.72, from revenue 67.65.

Piotroski score

3 / 9

A nine-point test of financial strength, for 30 Jun 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.